| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.25 | 2e-05 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.3 | 6e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0001 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |